Mayr-Melnhof Karton AG (MMK)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 64.80 |
|---|---|
| 52-week range | 64.40 – 102.40 |
| Return, 1 month / 3 months | −11.2% / −23.5% |
| Return, 1 year / 3 years | −17.8% / −38.4% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 32.4% |
| Worst drawdown (1 year) | -34.8% |
| Average daily value traded | 1.49M EUR |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mayr-Melnhof Karton is an Austrian manufacturer of cartonboard and folding cartons, based in Vienna. Its cartonboard business produces recycled and virgin fibre board at mills, while its packaging business converts board into printed folding cartons and other packaging. Customers are mainly consumer goods companies in food, confectionery, cosmetics, tobacco and household products, who use the packaging for branded retail goods across European and other markets.
Mayr-Melnhof Karton AG trades under the code MMK on the Vienna Exchange in Austria, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mayr-Melnhof Karton AG (MMK) trades on the Vienna Exchange in Austria. It last closed at EUR 64.80 on 22 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 62 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.8% and over the last three months it fell 23.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.0% | ||
| From 52-week high | -36.5% | ||
| Momentum | 16 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.5% | ||
| 6-month return | -24.9% | ||
| 12-month return, skipping the last month | -7.4% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.8% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 1.49M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −11.2% |
| 3 months | −23.5% |
| 6 months | −24.9% |
| 1 year | −17.8% |
| 3 years | −38.4% |
| 5 years | −57.6% |
Signals
| 50-day / 200-day average | 72.43 / 82.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | EUR 2.0000 |
| 7 May 2025 | EUR 1.8000 |
| 30 Apr 2024 | EUR 1.5000 |
| 3 May 2023 | EUR 4.2000 |
| 3 May 2022 | EUR 3.5000 |
| 5 May 2021 | EUR 3.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.